A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301) Meeting Abstract
| Authors: | Hansen, A. R.; Zhang, A. Y.; Boni, V.; Mantia, C.; Yu, E. Y.; Weickhardt, A. J.; Robert, M.; Gupta, S.; Morales-Barrera, R.; Hoimes, C. J.; Berlin, J.; Iyer, G.; Millward, M.; Lihou, C. F.; Loriot, Y.; Pouessel, D.; Mittal, K.; Hill, A. G.; Racca, F.; Tran, B. |
| Abstract Title: | A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301) |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454666200031 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.TPS904 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS904 -- Source: Wos |
